American Bitcoin Corp. (ABTC): Nasdaq/NYSE listing notice — Akerna receives Nasdaq bid price and equity deficiency notices; faces potential delisting

American Bitcoin Corp.

Bid price of common stock below $1.00 for 30 consecutive days; 180-day cure period until Sept 18, 2023.
Stockholders' equity of ($4,825,528) as of Dec 31, 2022, below Nasdaq's $2.5M minimum.
Must submit a plan to regain equity compliance by May 8, 2023; Nasdaq may grant up to 180 days.
Company does not meet alternative listing standards (market value or net income).
Failure to cure could lead to delisting and appeal to Nasdaq hearings panel.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

American Bitcoin Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 22, 2023, Akerna Corp. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Notice”). The Bid Price Notice has no immediate effect on

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

American Bitcoin Corp. filing history →

Source: SEC EDGAR

accession 0001213900-23-023738

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.